Katrin Kleinmanns
Bergen, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Establishment of a humanized patient-derived xenograft mouse model of high-grade serous ovarian cancer for preclinical evaluation of combination immunotherapy.
Journal: Molecular oncology
Published: December 13, 2025
Peripheral blood leukocyte signatures as biomarkers in relapsed ovarian cancer patients receiving combined anti-CD73/anti-PD-L1 immunotherapy in arm A of the NSGO-OV-UMB1/ENGOT-OV30 trial.
Journal: Molecular oncology
Published: January 02, 2025
Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16.
Journal: Journal for immunotherapy of cancer
Published: March 08, 2024
New immune phenotypes for treatment response in high-grade serous ovarian carcinoma patients.
Journal: Frontiers in immunology
Published: March 01, 2024
Combining Mass Cytometry Data by CyTOFmerge Reveals Additional Cell Phenotypes in the Heterogeneous Ovarian Cancer Tumor Microenvironment: A Pilot Study.
Journal: Cancers
Published: September 08, 2023
Fluorochrome Selection for Imaging Intraoperative Ovarian Cancer Probes.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 21, 2022
Xenograft Models of Ovarian Cancer for Therapy Evaluation.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: December 17, 2021
Comparison of Five Near-Infrared Fluorescent Folate Conjugates in an Ovarian Cancer Model.
Journal: Molecular imaging and biology
Published: May 31, 2021
Phenotypic Characterization by Mass Cytometry of the Microenvironment in Ovarian Cancer and Impact of Tumor Dissociation Methods.
Journal: Cancers
Published: January 04, 2021
The Emerging Role of CD24 in Cancer Theranostics-A Novel Target for Fluorescence Image-Guided Surgery in Ovarian Cancer and Beyond.
Journal: Journal of personalized medicine
Published: November 10, 2020
Last Updated: 09/26/2026